BREEDLOVE ROBERT CHARLES (Principal Accounting Officer) reported 1 transaction at PHATHOM PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/16/2026ACC: 0001193125-26-306165
Officer· Principal Accounting Officer
Since Feb 2026
-1.55K
Net shares
Net seller
$17.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.55K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.55K
Price / share
$11.04
Trade value
$17.16K
% of position
2.5%
7/14/2026
61.48K→59.92K
Total
Net shares
−1.55K
Net value
-$17.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/14/2026 | F · Tax Withholding | −1.55K | $11.04 | $17.16K | 2.5% | 61.48K | 59.92K |
| Total | −1.55K | -$17.16K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.95K
Total
6.95K indirect6.95K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.95K | Indirect |
| Total | 6.95K | 6.95K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported